Progyny Inc. (PGNY) - 5i Research

Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY

Q: Do you see the recent dip in PGNY as an opportunity or did the recent results indicate something worrying? Do you agree with the assessment that there could be long-term, above-average growth possibilities and PGNY is emerging as a leader rather than just simply another OK investment?

Read Answer Asked by John on March 05, 2024

Veeva Systems Inc. Class A (VEEV $286.01)
- $286.01 P/E (TTM): 60.55X Cap: $46.60B
- View VEEV Profile
- View Questions on VEEV
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY

Q: I'm reviewing my portfolio to evaluate if there are any names i've held for a few years which haven't done much or i'm down on, and may be candidates to be sold and replaced with growthier names that have become more attractive. The 2 names that meet the criteria are VEEV and PGNY. With a focus on growth do you think either of these names should be sold and replaced or are they holds? Thx

Read Answer Asked by Adam on June 21, 2023

STERIS plc (Ireland) (STE $225.47)
- $225.47 P/E (TTM): 36.08X Cap: $22.18B
- View STE Profile
- View Questions on STE
Progyny Inc. (PGNY $23.46)
- $23.46 P/E (TTM): 40.32X Cap: $1.96B
- View PGNY Profile
- View Questions on PGNY
Simulations Plus Inc. (SLP $13.27)
- $13.27 Cap: $262M
- View SLP Profile
- View Questions on SLP
Lantheus Holdings Inc. (LNTH $73.31)
- $73.31 P/E (TTM): 20.61X Cap: $5B
- View LNTH Profile
- View Questions on LNTH

Q: Hello,

I've had these three healthcare companies on my watchlist for some time. Can I get your up-to-date assessment of each re: growth prospects and balance sheet stability? Would you consider any of them to be a buy and if so, in what order and is the current valuation reasonable?

Thank you, Doris

Read Answer Asked by Doris on October 12, 2022